| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354709 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/08/2008 | CA2260909C Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 04/08/2008 | CA2231342C Pharmaceutical composition for oral delivery |
| 04/08/2008 | CA2187541C Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 04/03/2008 | WO2008039898A2 Methods for the treatment of a traumatic central nervous system injury |
| 04/03/2008 | WO2008039876A1 Cytokine signaling |
| 04/03/2008 | WO2008039863A2 Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
| 04/03/2008 | WO2008039514A1 Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration |
| 04/03/2008 | WO2008039359A2 Bicyclic pyrimidine kinase inhibitors |
| 04/03/2008 | WO2008039139A1 Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 04/03/2008 | WO2008039138A1 Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 04/03/2008 | WO2008039085A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | WO2008038849A1 Pharmaceutical composition comprising an extract from opuntia ficus-indica |
| 04/03/2008 | WO2008038771A1 Glutamine-containing composition for increasing blood flow |
| 04/03/2008 | WO2008038705A1 Glycation inhibitor |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038599A1 Axonal regeneration promoter |
| 04/03/2008 | WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/03/2008 | WO2008038155A2 Controlled-release pharmaceutical tablets |
| 04/03/2008 | WO2008037888A2 Tetracyclic compounds, process for the preparation thereof pharmaceutical compositions comprising the same and use thereof as dopaminergic receptor ligands |
| 04/03/2008 | WO2008037707A2 Valerian extract preparation |
| 04/03/2008 | WO2008037459A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | WO2008037418A1 Green tea medicinal extract, especially for use in the prophylaxis and treatment of diseases of the central nervous system or metabolic diseases, its use for producing a drug and method for producing the same |
| 04/03/2008 | WO2008037417A1 Green tea extract, especially for use as a functional food item, food supplement or corresponding ingredient, the use thereof and method for producing said green tea extract |
| 04/03/2008 | WO2008037415A1 Use of theanine for producing a drug for use in the prophylaxis and treatment of psychiatric disorders of the central nervous system, especially of depressions and pains |
| 04/03/2008 | WO2008037258A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 04/03/2008 | WO2008037182A1 Use of ginsenoside rg1 for treatment of cerebral ischemia and/or diseases or symptoms induced by cerebral ischemia |
| 04/03/2008 | WO2008021545A3 Modulators of muscarinic receptors |
| 04/03/2008 | WO2008012622A3 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 04/03/2008 | WO2008008114A3 Use of adipose-derived stem cells for treatment of leukodystrophies |
| 04/03/2008 | WO2008004013A3 Medicament for the enhancement of cognitive function and neuroprotection |
| 04/03/2008 | WO2007146284A3 Thienopyrimidines useful as modulators of ion channels |
| 04/03/2008 | WO2007135131A9 Substituted pyrazinone derivatives for use as a medicine |
| 04/03/2008 | WO2007128674A3 Muscarinic agonists to treat impulse control disorders |
| 04/03/2008 | WO2007109288A3 Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 04/03/2008 | WO2006114666A8 SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES |
| 04/03/2008 | US20080081839 Compounds useful for treating neurological disorders |
| 04/03/2008 | US20080081834 Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| 04/03/2008 | US20080081833 1-(5-cyclopropyl-2-phenyl-2H-pyrazol-3-yl)-3-(4-ethoxyphenyl)urea; 1-(5-cyclopropyl-2-phenyl-2H-pyrazol-3-yl)-3-(4-ethoxyphenyl)urea; anxiolitic and antidepressant agent; myasthenia gravis, neurodegenerative disorders, nicotine addiction |
| 04/03/2008 | US20080081832 Imidazole derivatives, processes for preparing them and their uses |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081820 SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES |
| 04/03/2008 | US20080081819 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; glycogen synthase kinase-3 beta inhibitor; neurodegenerative disease, non-insulin dependent diabetes; inhibit amyloid precursor protein and tau protein hyperphosphorylation |
| 04/03/2008 | US20080081804 Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic Disorders |
| 04/03/2008 | US20080081355 Activatable recombinant neurotoxins |
| 04/03/2008 | US20080081068 Modified release formulations of a bupropion salt |
| 04/03/2008 | US20080081067 First sustained release portion of core with functional coating; second portion with core and separator with functional coating; excipients; treating depressive, anxiety, and panic disorder; rate controlling polymer of ethyl acrylate, methyl methacrylate and trimethylammonioethyl methacrylate |
| 04/03/2008 | US20080081032 Using reovirus construct as therapeutic tool to decrease pain associated with treatment of cell proliferative disorders |
| 04/03/2008 | DE102006046745A1 Use of spirocyclic cyclohexane-derivative exhibiting an affinity for opioid-receptor and opioid receptor-like-1-receptor, for producing a medicament e.g. for treating diabetic neuropathy, for narcosis or for analgesia during narcosis |
| 04/03/2008 | DE102006045764A1 Verwendung von Theogallin zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von neurologischen und psychiatrischen Erkrankungen des zentralen Nervensystems, insbesondere von mentalen Konzentrationsleistungsstörungen, Depression und Demenz Using theogallin for producing a medicament for the prophylaxis and treatment of neurological and psychiatric diseases of the central nervous system, in particular of mental concentration performance disorders, depression and dementia |
| 04/03/2008 | CA2664930A1 Novel 5,7-disubstituted[1,3]thiazolo[4,5-d]pyrimidin-2(3h)-amine derivatives and their use in therapy |
| 04/03/2008 | CA2664789A1 5,7-disubstituted[1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives for the selective inhibtion of chemokine receptors |
| 04/03/2008 | CA2664744A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | CA2664375A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | CA2664359A1 Cytokine signaling |
| 04/03/2008 | CA2664358A1 Diarylketimine derivative |
| 04/03/2008 | CA2664258A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 04/03/2008 | CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/03/2008 | CA2564151A1 Marker for tardive dyskinesia |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905775A1 Tetracyclic compounds, method of preparing them, pharmaceutical compositions containing them and their use as dopamine receptors ligands |
| 04/02/2008 | EP1905774A1 Fused heterocyclic compounds as serotonin receptor modulators |
| 04/02/2008 | EP1905771A2 Quinuclidine derivatives and their use |
| 04/02/2008 | EP1905765A1 6-arylamino-5-cyano-4-pyrimidinone as PDE9A-inhibitors |
| 04/02/2008 | EP1905762A1 Pyrazolone derivative |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905448A2 Selection of patients with increased responsiveness to botulinum toxin |
| 04/02/2008 | EP1905441A2 Non-sedating barbiturate compounds as neuroprotective agents |
| 04/02/2008 | EP1904493A1 Tetrahydroprotoberberine compounds, the synthetic method and the use thereof |
| 04/02/2008 | EP1904483A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 04/02/2008 | EP1904447A1 Piperidine carboxamide derivate suitable as tachykinin receptor antagonist |
| 04/02/2008 | EP1904442A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 04/02/2008 | EP1904182A2 Method for the treatment of drug abuse with flibanserin |
| 04/02/2008 | EP1904104A2 Sp35 antibodies and uses thereof |
| 04/02/2008 | EP1904069A2 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 04/02/2008 | EP1904068A1 Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) |
| 04/02/2008 | EP1904066A2 Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| 04/02/2008 | EP1904063A1 Thiazole derivatives for the treatment of dyskinesias caused by a chemical treatment |
| 04/02/2008 | EP1904062A1 Thiazole derivatives for the treatment of restless legs syndrome |
| 04/02/2008 | EP1904059A2 Method for treating nervous system disorders and conditions |
| 04/02/2008 | EP1904058A2 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist |
| 04/02/2008 | EP1904055A1 Composition for inhibiting acyl-coa:cholesterol acyltransferase |
| 04/02/2008 | EP1904049A2 Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
| 04/02/2008 | EP1904046A2 Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| 04/02/2008 | EP1904029A2 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug |
| 04/02/2008 | EP1793817A4 Methods of treating a disorder |
| 04/02/2008 | EP1729759A4 Salvinorin derivatives and uses thereof |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1274729B1 G protein coupled receptor |
| 04/02/2008 | EP1265610A4 Method for reducing or eliminating smoking |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | CN101155818A Substituted propane phosphinic acid esters |
| 04/02/2008 | CN101155814A Crystals of morphinan derivative and process for producing the same |
| 04/02/2008 | CN101155804A Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 04/02/2008 | CN101155796A Imidazole derivatives |
| 04/02/2008 | CN101155793A Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |